Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathology. The platform can assist in linking a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Individual development of treatment programs for treatment and management of infant epilepsy is often required, including drug therapy, rehabilitation, prevention, and regular follow-up.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many formerly difficult-to-treat neurological disorders have been significantly improved. Treatment requires close monitoring of efficacy and adverse reactions and timely adjustment to changes in the course of the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of infant epilepsy.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.